Department of Endocrinology, Diabetes Center, Institute of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Department of Endorcrinology, The Third Xiangya Hospital, Central South University, Changsha, 410007, Hunan, People's Republic of China.
J Endocrinol Invest. 2015 Feb;38(2):149-54. doi: 10.1007/s40618-014-0162-x. Epub 2014 Sep 4.
The aim of this study was to investigate the association of cytotoxic T-lymphocyte antigen-4 (CTLA-4) + 49A/G and CT60 polymorphisms with latent autoimmune diabetes in adults (LADA) and the genetic differences between LADA, type 1 diabetes (T1DM), and type 2 diabetes (T2DM) in a Chinese population.
A total of 231 LADA, 402 T1DM, and 330 T2DM patients as well as 482 nondiabetic controls were recruited in the study.
CTLA-4 + 49A/G and CT60 polymorphisms were analyzed by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). The level of glutamic acid decarboxylase antibodies (GADAs) was detected by a radioligand binding assay.
The CTLA-4 + 49A/G risk genotype GG was most frequent in T1DM patients (45.3%), followed by LADA patients (44.2%) and T2DM patients (38.8%). Significantly higher frequencies of the risk genotype GG were observed in the T1DM (OR = 1.532, 95% CI 1.168-2.010, P = 0.002) and LADA patients (OR = 1.464, 95% CI 1.063-2.017, P = 0.019). The frequencies of the CTLA-4 CT60 risk genotype GG were 65.2, 61.9, 58.5, and 56.4% in the T1DM, LADA, T2DM, and control groups, respectively. The CTLA-4 CT60 GG risk genotypes were only associated with T1DM (OR = 1.445, 95% CI 1.1-1.898, P = 0.008). Compared with controls, patients having a high titer of GADA (GADA ≥ 180 IU/ml) had higher frequencies of the GG risk genotype of CTLA-4 + 49 A/G (49.4% vs. 35.1% OR = 1.807, 95% CI 1.125-2.903, P = 0.014), but there was no difference between patients having a low titer of GADA and controls.
The CTLA-4 + 49 A/G polymorphism confers genetic susceptibility to LADA and T1DM, while the CTLA-4 CT60 polymorphism is only associated with T1DM in Chinese population. The CTLA-4 + 49 A/G genotype distribution in LADA is associated with the GADA level.
本研究旨在探讨细胞毒性 T 淋巴细胞相关抗原 4(CTLA-4)+49A/G 和 CT60 多态性与成人隐匿性自身免疫性糖尿病(LADA)的关联,以及在中国人群中 LADA、1 型糖尿病(T1DM)和 2 型糖尿病(T2DM)之间的遗传差异。
本研究共纳入 231 例 LADA 患者、402 例 T1DM 患者、330 例 T2DM 患者和 482 名非糖尿病对照者。
采用聚合酶链反应限制性片段长度多态性(PCR-RFLP)分析 CTLA-4+49A/G 和 CT60 多态性。采用放射配体结合法检测谷氨酸脱羧酶抗体(GADA)水平。
T1DM 患者中 CTLA-4+49A/G 风险基因型 GG 最为常见(45.3%),其次是 LADA 患者(44.2%)和 T2DM 患者(38.8%)。T1DM(OR=1.532,95%CI 1.168-2.010,P=0.002)和 LADA 患者(OR=1.464,95%CI 1.063-2.017,P=0.019)中风险基因型 GG 的频率显著更高。CTLA-4 CT60 风险基因型 GG 的频率分别为 T1DM、LADA、T2DM 和对照组中的 65.2%、61.9%、58.5%和 56.4%。CTLA-4 CT60 GG 风险基因型仅与 T1DM 相关(OR=1.445,95%CI 1.1-1.898,P=0.008)。与对照组相比,GADA 滴度较高(GADA≥180IU/ml)的患者 GG 风险基因型的频率更高(49.4%比 35.1%,OR=1.807,95%CI 1.125-2.903,P=0.014),但 GADA 滴度较低的患者与对照组之间没有差异。
CTLA-4+49A/G 多态性赋予了 LADA 和 T1DM 的遗传易感性,而 CTLA-4 CT60 多态性仅与中国人群中的 T1DM 相关。LADA 中的 CTLA-4+49A/G 基因型分布与 GADA 水平相关。